Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination of allergen extracts from house dust mites, various animal epithelia (dander), and molds, used for allergen immunotherapy. This treatment is intended for patients with diagnosed allergies to these specific perennial, indoor allergens. [9, 11] Immunotherapy involves the administration of gradually increasing doses of the allergens to which the person is sensitive. [7] This process helps the immune system build tolerance, reducing the severity of allergic symptoms over time. [1, 7] Such combinations are typically prescribed by an allergist as custom-formulated mixtures for subcutaneous injections (allergy shots) or sublingual drops, based on a patient's specific sensitization profile determined through allergy testing. [2, 14]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on house dust mite + animal epithelia + mold.